ENVALITH
株式会社ファルコホールディングス logo

FALCO HOLDINGS Co., Ltd.

4671Standard MarketServices

株式会社ファルコホールディングス logo
FALCO HOLDINGS Co., Ltd.4671
Reference Indicators

Market Cap

288¥100M

P/E (Forecast)

13.4x

P/B

1.0x

Dividend Yield (Forecast)

4.74%

ROE

7.9%

EV/EBITDA

5.8x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
50,00746,91343,00743,31343,578
Cost of Sales
32,68332,26930,08429,95629,766
Gross Profit
17,32314,64412,92313,35713,811
SG&A Expenses
11,82711,56810,77011,02211,313
Operating Income
5,4963,0752,1522,3352,498
Non-operating Income
351267189215206
Non-operating Expenses
3832535016
Ordinary Income
5,8093,3102,2882,4992,689
Extraordinary Income
70601415401430
Extraordinary Losses
31221613012337
Pre-tax Income
5,5673,6952,5722,7773,082
Income Taxes
2,0341,4339058571,065
Net Income
3,5332,2611,6661,9202,016
EBITDA
6,4544,1163,1303,2763,559
Gross Margin
34.6%31.2%30.0%30.8%31.7%
Operating Margin
11.0%6.6%5.0%5.4%5.7%
ROA
8.8%5.8%4.6%5.3%5.5%
ROE
16.1%9.1%6.4%7.5%7.9%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
臨床検査事業26,6621,8166.8%
調剤薬局事業15,1956744.4%
ICT事業1,72045826.6%